Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma. (30th January 2018) - Smyth, Liam; Buckstein, Rena; Pennell, Nancy; Weerasinghe, Rashmi; Cheung, Matthew C.; Imrie, Kevin; Spaner, David; Piliotis, Eugenia; Chodirker, Lisa; Reis, Marciano; Ghorab, Zeina; Zhang, Liying; et al.